Skip to content

Safety & Feasibility of Functional Electrical Stimulation for The Treatment of Premature Ejaculation

Safety & Feasibility of Functional Electrical Stimulation for The Treatment of Premature Ejaculation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03177226
Enrollment
30
Registered
2017-06-06
Start date
2017-01-31
Completion date
2017-12-31
Last updated
2017-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Ejaculation

Brief summary

Prospective, non-randomized, controlled, single-center study, to evaluate the efficacy of applied nominal electrical stimulation parameters given to premature ejaculation (PE) patients in order to prolong the ejaculatory latency time which will eventually increase the quality of their sexual life.

Interventions

DEVICEFunctional TENS stimulation

A short continuous electrical stimulation, beginning at 0 mAmp and gradually increased by +0.5 mAmp every 2-10 sec to identifying Sensory Threshold (Is) and Motor Threshold (Imc), followed by continuous functional electrical stimulation, throughout the entire self-stimulation phase, equal to his Icm'

DEVICENon-Functional TENS stimulation

A short continuous electrical stimulation, beginning at 0 mAmp and gradually increased by +0.5 mAmp every 2-10 sec to identifying Sensory Threshold (Is) and Motor Threshold (Imc), followed by continuous non-functional electrical stimulation, throughout the entire self-stimulation phase, equal to his Icm'

Sponsors

Virility Medical Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DEVICE_FEASIBILITY
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Good general health * Clinical history of premature ejaculation * Familiar with self- stimulation * Ability to follow study instructions and complete study assessment tools * Washout period of two weeks

Exclusion criteria

* History of cardio-vascular disorders * Any type of implanted pacemaker/defibrillator * Hypertension * Diabetes Mellitus * Local dermatological disease * Local skin irritation/ lesions * Any neurological disorder * Any psychiatric disease and/or any psychiatric medications * Any neoplastic disease in the past two years

Design outcomes

Primary

MeasureTime frameDescription
Incidence of Treatment-Emergent Adverse EventsProcedure dayAll Self reported safety events (e.g. discomfort, pain, local irritation, local heat, noticeable changes in urination or bowl activity or any other complaint)
Change in ejaculation latency timeProcedure dayThe difference between patient ejaculation latency time under perineal functional electrical stimulation during self-stimulation, and latency time during self-stimulation while no electrical stimulation is applied

Secondary

MeasureTime frameDescription
Incidence of post-treatment Adverse Events72 hoursPost treatment safety evaluation completed by subjects (using safety questionnaire)

Other

MeasureTime frameDescription
Effects of applied electrical stimulation on Erection using Self Reported - User QuestionnaireProcedure daySelf reported - user questionnaire

Countries

Israel

Contacts

Primary ContactIlan Gruenwald, MD
+972-4-777-2819

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026